Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 72789-435

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 72789-435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Wallet (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 01)

An illustrated medication calendar for a kit of norgestimate and ethinyl estradiol showing a weekly pill schedule arranged by day of the week (Sunday to Saturday) across four weeks. Arrows indicate the order to take each pill. A note instructs placement of a day label strip if the period starts on a day other than Sunday. There is also a reminder for a monthly self breast exam.*

FDA Label Image

Image (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 02)

A forest plot chart titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use' showing effect estimates (odds ratios or relative risks) with confidence intervals from multiple studies. The x-axis represents the effect estimate ranging from -1.5 to 2, with a vertical reference line at 1. Each study's result is plotted as a point with error bars indicating confidence intervals, comparing ever use and current use across six studies from 2002 to 2017.*

FDA Label Image

Image Structure (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 03)

Chemical structure diagrams of norgestimate and ethinyl estradiol, the active ingredients in the product norgestimate and ethinyl estradiol. The diagrams illustrate the molecular structure of each hormone component.*

FDA Label Image

Image Med Guide (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 04)

An illustration comparing pregnancy rates per 100 women in one year with various birth control methods, ordered from fewer pregnancies to more pregnancies. It lists implants, injections, intrauterine devices, and sterilization as most effective, followed by birth control pills, skin patch, and vaginal ring with hormones. Condoms and diaphragm are next, then behavioral methods, spermicides, and withdrawal, with no birth control resulting in the highest pregnancies.*

FDA Label Image

Image A-w Wallet (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 05)

An instructional calendar panel for a norgestimate and ethinyl estradiol oral contraceptive kit. It displays a 4-week layout with rows labeled Week 2, Week 3, and Week 4, and columns for days Sunday through Saturday. Arrows indicate the order of daily pill intake starting at Sunday. The panel includes guidance to place a day label strip starting with the first day of the user's period and a reminder for a monthly self breast exam.*

FDA Label Image

Wallet (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 06)

Label and blister card for Tri-Lo-Marzia tablets containing norgestimate and ethinyl estradiol with varying dosages of 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg. The label shows storage instructions and distributor/manufacturer information from Lupin Pharmaceuticals and Lupin Limited. The blister card features a 4-week dosing schedule with circles representing daily tablets arranged by day of the week and week number.*

FDA Label Image

Pouch (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 07)

Packaging label for Tri-Lo-Marzia, a kit containing norgestimate and ethinyl estradiol tablets. Dosages listed are 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg. The label indicates one blister pack with 28 tablets. Manufactured by Lupin Pharmaceuticals, the label includes directions and safety warnings on oral contraceptive use.*

FDA Label Image

72789435 Label (72789435)

Label for a norgestimate and ethinyl estradiol kit containing 28 tablets. Each tablet has a strength of 0.180 mg/0.025 mg. The label includes the NDC number 72789-435-79 and is marked Rx only. Manufactured by PD-Rx Pharmaceuticals, Inc., located in Oklahoma City, OK. The label also provides reorder information, lot number LA00485, and expiration date of 01/2026.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.